Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Ichikawa

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Biorxiv : the Preprint Server for Biology|July 11, 2025
Structure-guided design and development of cyclic peptide allosteric activators of Polycomb Repressive Complex 2Yasuaki Tokodai, Mark Matyas, Azumi Ishigamori, et al.
Japanese Journal of Clinical Oncology|July 29, 2021
Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapyTakahiro Yamauchi, Chikashi Yoshida, Kensuke Usuki, et al.
Communications Chemistry|January 25, 2023
β-Hydroxylation of α-amino-β-hydroxylbutanoyl-glycyluridine catalyzed by a nonheme hydroxylase ensures the maturation of caprazamycinSaeid Malek Zadeh, Mei-Hua Chen, Zhe-Chong Wang, et al.
European Journal of Haematology|June 15, 2023
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trialAlexander Röth, Satoshi Ichikawa, Yoshikazu Ito, et al.
British Journal of Haematology|November 5, 2020
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label studyJun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2021
Structure, solubility, and permeability relationships in a diverse middle molecule libraryHiroyuki Miyachi, Kayoko Kanamitsu, Mayumi Ishii, et al.
Annals of Hematology|July 1, 2025
Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trialsJun Ho Jang, Kinuko Mitani, Yoshiaki Tomiyama, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 14, 2022
Enabling Long Cycle Life and High Rate Iron Difluoride Based Lithium Batteries by In Situ Cathode Surface ModificationYong Su, Jingzhao Chen, Hui Li, et al.
International Journal of Hematology|July 21, 2018
Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trialKen Ohmachi, Kensei Tobinai, Tomohiro Kinoshita, et al.
Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Biorxiv : the Preprint Server for Biology|July 11, 2025
Structure-guided design and development of cyclic peptide allosteric activators of Polycomb Repressive Complex 2Yasuaki Tokodai, Mark Matyas, Azumi Ishigamori, et al.
Japanese Journal of Clinical Oncology|July 29, 2021
Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapyTakahiro Yamauchi, Chikashi Yoshida, Kensuke Usuki, et al.
Communications Chemistry|January 25, 2023
β-Hydroxylation of α-amino-β-hydroxylbutanoyl-glycyluridine catalyzed by a nonheme hydroxylase ensures the maturation of caprazamycinSaeid Malek Zadeh, Mei-Hua Chen, Zhe-Chong Wang, et al.
European Journal of Haematology|June 15, 2023
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trialAlexander Röth, Satoshi Ichikawa, Yoshikazu Ito, et al.
British Journal of Haematology|November 5, 2020
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label studyJun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2021
Structure, solubility, and permeability relationships in a diverse middle molecule libraryHiroyuki Miyachi, Kayoko Kanamitsu, Mayumi Ishii, et al.
Annals of Hematology|July 1, 2025
Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trialsJun Ho Jang, Kinuko Mitani, Yoshiaki Tomiyama, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 14, 2022
Enabling Long Cycle Life and High Rate Iron Difluoride Based Lithium Batteries by In Situ Cathode Surface ModificationYong Su, Jingzhao Chen, Hui Li, et al.
International Journal of Hematology|July 21, 2018
Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trialKen Ohmachi, Kensei Tobinai, Tomohiro Kinoshita, et al.
Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.
Pageof 25